ENTX- Entera Bio Ltd.
Entera Bio Ltd. (ENTX) has 4 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. ENTX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 188.1K | $530.4K | - | |
| Dir | 40.0K | $112.8K | - | |
| Dir | 15.0K | $42.3K | - | |
| Dir | 0 | - | - |
Activity
Buys and sells only
Transactions
7 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Germano Geno J62 | Director | Buy | 20,000 | $1.30 | $26,000.00 | +100.0% | -11.3% | - | |
| Mar 5, 2026 | Ellis Sean | Director | Buy | 10,000 | $1.23 | $12,300.00 | +5.6% | -0.8% | - | |
| Feb 12, 2026 | Rubin Steven D68 | Director | Buy | 5,000 | $1.49 | $7,450.00 | +50.0% | -15.1% | - | |
| Feb 10, 2026 | Taitel Haya | Director | Buy | 7,500 | $1.48 | $11,100.00 | -100% | -10.3% | - | |
| Feb 10, 2026 | Germano Geno J62 | Director | Buy | 20,000 | $1.49 | $29,800.00 | -100% | -10.3% | - | |
| Feb 9, 2026 | Rubin Steven D68 | Director | Buy | 10,000 | $1.20 | $12,000.00 | New | -2.3% | - | |
| Feb 9, 2026 | Ellis Sean | Director | Buy | 18,000 | $1.24 | $22,320.00 | +11.2% | -2.3% | - |